We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NWBO Northwest Biotherapeutics Inc (QB)

0.0395 (7.21%)
Mar 01 2024 - Closed
Delayed by 15 minutes

Northwest Biotherapeutics (QB) Financial Summary

The current NWBO market cap is 677.89M. The company's latest EPS is USD -0.0910 and P/E is -1.87.

Year End December 30 2022 20182019202020212022
Total Revenue 412k2.41M1.29M1.01M1.68M
Operating Income -44.76M-27.46M-86.61M-52.7M-67.18M
Net Income -53.64M-20.3M-529.82M179.13M-105.03M
Year End December 30 2022 20182019202020212022
Total Assets 24.67M9.13M32.9M40.16M31.32M
Total Liabilities 71.83M52.7M395.85M164.15M136.37M
Total Equity -47.16M-43.57M-362.95M-123.99M-128.1M

Cash Flow

Year End December 30 2022 20182019202020212022
Operating -34.59M-31.86M-32.09M-38.3M-52.78M
Investing 45.4M-360k-8.14M-6.02M-2.9M
Financing 7.87M9.95M52.7M48.13M41.97M
Market Cap 677.89M
Price to Earnings Ratio -1.87
Price to Sales Ratio 113.33
Price to Cash Ratio 28.33
Price to Book Ratio -1.87
Dividend Yield -

Share Statistics

Shares Outstanding 1.15B
Average Volume (1 week) 1.83M
Average Volume (1 Month) 1.77M
52 Week Change -16.07%
52 Week High 1.11
52 Week Low 0.4001
Spread (Intraday) 0.09 (13.83%)

Company Info

Company Name Northwest Biotherapeutics Inc (QB)
Address 251 little falls drive
wilmington, delaware 19808
Website https://
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |